SAR97276A
Phase 2Terminated 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Malaria
Conditions
Malaria
Trial Timeline
Aug 1, 2008 → Jun 1, 2009
NCT ID
NCT00739206About SAR97276A
SAR97276A is a phase 2 stage product being developed by Sanofi for Malaria. The current trial status is terminated. This product is registered under clinical trial identifier NCT00739206. Target conditions include Malaria.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00739206 | Phase 2 | Terminated |
Competing Products
20 competing products in Malaria